Interphex Tokyo 2025

Holodiag and Icrom were at Interphex Japan at Tokyo Big Sight! 🎌 INTERPHEX WEEK is Japan’s largest B-to-B trade show for pharmaceutical, biotechnology, and regenerative medicine technologies. The Icrom team from Italy, specialized in high-tech APIs, was there together with the Holodiag team from France, expert in solid-state and crystallization. We were teaming up to […]
BOS Basel 2025

Another amazing week at BOS Basel 2025 for Holodiag – Now part of Icrom! This time with Icrom Srl. Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. Thank you to everyone who made it such a success, including Zool Agency. […]
Chemspec Cologne 2025

Chemspec Europe is a key event for the fine and speciality chemicals industry. With a highly specialised profile, the exhibition is the place to be for purchasers and agents to meet with manufacturers, suppliers and distributors of fine and speciality chemicals to source specific solutions and products. Who would’ve thought the unexpected Chemspec Europe – […]
Access to pure enantiomer is a critical challenge for API process development

🔴 Besides from asymmetric synthesis, enantiomer separation is a very effective option, especially by crystallization. Holodiag’s acute expertise in this field opens various options, starting from racemic or excess mixtures, with or without resolving agents. Thus, efficient and cost-effective process can be accurately assessed and developed. ✅ Dedicated analytical techniques support such development. Among them […]
Electron diffraction: the simplest and fastest way to determine crystal structures

Electron diffraction is the most recent addition to the crystallographic toolkit and allows researchers to determine crystal structures directly from nanocrystals of sizes around 10-1000 nm. The ELDICO ED-1 – is designed by crystallographers for crystallographers with many different applications. What’s new ? With X-Ray diffraction We need to grow a single crystal “big” enough […]
DCAT Week NYC 2025

And that’s a wrap — #DCAT Week 2025 has come to an end! A successful first participation for #Holodiag alongside the great #Icrom team. We’re grateful for the insightful meetings and valuable connections made. Definitely the best way to establish our presence in the USA! Already looking forward to next year! 🌎 🤝 #pharma #USA […]
Electron diffraction: what applications for pharmaceutical development ?

❕ Few weeks ago, we announced the acquisition of the ELDICO ED-1 electron diffractometer, state-of-the-art equipment. What applications for pharmaceutical development ? The growth of single crystals has limits: it guarantees neither success nor control of the desired polymorphic form. On the other hand, thanks to electron diffraction, a single grain of powder is enough […]
New recruitment: Clément PINETRE,PhD as Crystallization researcher

👨🔬 Thrilled to welcome Clement Pinetre to Holodiag as our new crystallization researcher! His expertise in polymorphism, crystallization and solid state will be a key asset in pushing the boundaries of solid-state innovation. Recently graduated at the university of Rouen, his thesis was about “Achieving Enantiοpurity Τhrοugh Directed Evοlutiοn and Crystallizatiοn under Νοn-Equilibrium Cοnditiοns” Welcome […]
Holodiag is proud to announce the acquisition of an electron diffractometer: the ELDICO ED-1

‼️ UPCOMING BIG NEW TOY FOR THE LAB ‼️ Holodiag is proud to announce the acquisition of an electron diffractometer: the ELDICO ED-1. Becoming the first company in Europe having such an equipment, we warmly thank ELDICO Scientific AG and particularly Danny Stam for his professional skills and the high level technical discussions. As part of Icrom Srl and Proxis Developpement, this investment […]
DCAT Member!

Holodiag is proud to join DCAT (Drug, Chemical & Associated Technologies Association), the premier association for the global bio-pharmaceutical manufacturing value chain. A new step for our company which continues to progress 👌